DelveInsight’s Growth Hormone Deficiency (GHD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Growth Hormone Deficiency (GHD) for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Growth Hormone Deficiency (GHD) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Growth Hormone Deficiency (GHD) till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Growth Hormone Deficiency (GHD) market.
• Identifying patient populations in the global “Growth Hormone Deficiency (GHD) market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Growth Hormone Deficiency (GHD) therapeutics in each of the markets covered.
• To understand the future market competition in the global Growth Hormone Deficiency (GHD) therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2023.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Growth Hormone Deficiency (GHD) for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
Note: This report requires 7-10 business days to complete.
'
Table of Contents
• Growth Hormone Deficiency (GHD) overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Growth Hormone Deficiency (GHD) Market
• Global Epidemiology of Growth Hormone Deficiency (GHD) Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Growth Hormone Deficiency (GHD) Drug Sales (USD Millions)
• Table 6: Global Epidemiology of Growth Hormone Deficiency (GHD) (2013-2023)
• Table 7: Growth Hormone Deficiency (GHD) Global Market (USD Millions), (2013-2015)
• Table 8: Growth Hormone Deficiency (GHD) Global Market (USD Millions), (2016-2023)
• Table 9: Growth Hormone Deficiency (GHD) US Market (USD Millions), (2013-2015)
• Table 10: Growth Hormone Deficiency (GHD) US Market (USD Millions), (2016-2023)
• Table 11: Growth Hormone Deficiency (GHD) Germany Market (USD Millions), (2013-2015)
• Table 12: Growth Hormone Deficiency (GHD) Germany Market (USD Millions), (2016-2023)
• Table 13: Growth Hormone Deficiency (GHD) United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Growth Hormone Deficiency (GHD) United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Growth Hormone Deficiency (GHD) France Market (USD Millions), (2013-2015)
• Table 16: Growth Hormone Deficiency (GHD) France Market (USD Millions), (2016-2023)
• Table 17: Growth Hormone Deficiency (GHD) Italy Market (USD Millions), (2013-2015)
• Table 18: Growth Hormone Deficiency (GHD) Italy Market (USD Millions), (2016-2023)
• Table 19: Growth Hormone Deficiency (GHD) Spain Market (USD Millions), (2013-2015)
• Table 20: Growth Hormone Deficiency (GHD) Spain Market (USD Millions), (2016-2023)
• Table 21: Growth Hormone Deficiency (GHD) Japan Market (USD Millions), (2013-2015)
• Table 22: Growth Hormone Deficiency (GHD) Japan Market (USD Millions), (2016-2023)
• Table 23: Growth Hormone Deficiency (GHD) ROW Market (USD Millions), (2013-2015)
• Table 24: Growth Hormone Deficiency (GHD) ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Growth Hormone Deficiency (GHD) Drug Sales (USD Millions)
• Figure 2: Global Epidemiology of Growth Hormone Deficiency (GHD) (2013-2023)
• Figure 3: Growth Hormone Deficiency (GHD) Global Market (USD Millions), (2013-2015)
• Figure 4: Growth Hormone Deficiency (GHD) Global Market (USD Millions), (2016-2023)
• Figure 5: Growth Hormone Deficiency (GHD) US Market (USD Millions), (2013-2015)
• Figure 6: Growth Hormone Deficiency (GHD) US Market (USD Millions), (2016-2023)
• Figure 7: Growth Hormone Deficiency (GHD) Germany Market (USD Millions), (2013-2015)
• Figure 8: Growth Hormone Deficiency (GHD) Germany Market (USD Millions), (2016-2023)
• Figure 9: Growth Hormone Deficiency (GHD) United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Growth Hormone Deficiency (GHD) United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Growth Hormone Deficiency (GHD) France Market (USD Millions), (2013-2015)
• Figure 12: Growth Hormone Deficiency (GHD) France Market (USD Millions), (2016-2023)
• Figure 13: Growth Hormone Deficiency (GHD) Italy Market (USD Millions), (2013-2015)
• Figure 14: Growth Hormone Deficiency (GHD) Italy Market (USD Millions), (2016-2023)
• Figure 15: Growth Hormone Deficiency (GHD) Spain Market (USD Millions), (2013-2015)
• Figure 16: Growth Hormone Deficiency (GHD) Spain Market (USD Millions), (2016-2023)
• Figure 17: Growth Hormone Deficiency (GHD) Japan Market (USD Millions), (2013-2015)
• Figure 18: Growth Hormone Deficiency (GHD) Japan Market (USD Millions), (2015-2023)
• Figure 19: Growth Hormone Deficiency (GHD) ROW Market (USD Millions), (2013-2015)
• Figure 20: Growth Hormone Deficiency (GHD) ROW Market (USD Millions), (2016-2023)
• Novo Nordisk
• Nautilus Biotech
• Genexine
• Versartis
• AEterna Zentaris Inc.
• Ambrx
• Ascendis Pharma
